Primary Care Diabetes
Volume 1, Issue 4 , Pages 187-193, December 2007

Cognitive dysfunction and diabetes: Implications for primary care

  • Geert Jan Biessels

      Affiliations

    • Department of Neurology, Rudolf Magnus Institute of Neurosciences, University Medical Center Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Neurology G03.228, University Medical Center Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands. Tel.: +31 30 2508600; fax: +31 30 2542100.
  • ,
  • Anneloes Kerssen

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
  • ,
  • Edward H.F. de Haan

      Affiliations

    • Helmholtz Research Institute, Utrecht University, The Netherlands
  • ,
  • L. Jaap Kappelle

      Affiliations

    • Department of Neurology, Rudolf Magnus Institute of Neurosciences, University Medical Center Utrecht, The Netherlands

Received 6 September 2007; accepted 11 October 2007. published online 22 November 2007.

Summary 

It is increasingly recognized that diabetes mellitus can lead to long-term complications in the brain. Clinically, these complications are manifested in alterations in cognitive functioning. This paper offers an overview on the impact of diabetes on cognition and provides leads for the evaluation and management of cognitive disturbances in patients with diabetes in a primary care setting. The main message is that while some patient groups appear to be at increased risk of cognitive impairments, in the majority of patients diabetes is not associated with the development cognitive decrements that would be regarded as clinically relevant. Frank impairments of cognition mainly occur in patients above the age of 65, often in association with vascular co-morbidity. Other groups at risk for cognitive decrements are children with an early age at diabetes onset and patients with clinically manifest retinopathy or other microvascular complications. No specific treatment options are available, but for now treatment of vascular risk factors and attention for glycaemic control appears to be a logical approach. Given the recent progress in this field, new treatments to prevent cognitive impairment in patients with diabetes may hopefully become available in the near future.

Keywords: Diabetes mellitus, Cognition, Dementia, Brain, MRI

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1751-9918(07)00110-6

doi:10.1016/j.pcd.2007.10.002

Primary Care Diabetes
Volume 1, Issue 4 , Pages 187-193, December 2007